News

HOOKIPA Pharma Inc. announced that it has achieved a further research milestone in its collaboration and license agreement with Gilead Sciences, Inc.…

Repeated significant growth in IXIARO® revenues; Lyme disease and chikungunya programs advancing towards major data points; R&D investor day planned…

A new research award seeks to honour the World’s most outstanding PhD projects in molecular life sciences from the past year. The international…

Two-mentor scheme, opportunities for a two-month secondment and support by an inter-sectoral advisory board. The call for applications is open until…

Together with an international group of researchers, Youssef Belkhadir's lab at the GMI has identified a new class of bacterial molecules that trigger…

Max F. Perutz Laboratories group leader Andreas Bachmair has been promoted to full Professor of Genetics and Biochemistry by the University of Vienna.…

Valneva will present on its Lyme disease and chikungunya vaccine candidates on April 16th, 2019 at the 19th World Vaccine Congress in Washington, D.C.

Structural biologists in the lab of IMP senior scientist Tim Clausen have characterised the structure of the protein arginine kinase McsB, a novel…

The Austrian Science Fund FWF has awarded a doc.funds grant totalling more than €1.7 million to a consortium of stem cell researchers at the Vienna…

The Vienna BioCenter PhD Programme invites all Master Students interested in pursuing a PhD in Life Sciences to an Open Day on Friday 12 April.

The first "Vienna BioCenter cryo EM Symposium" will take place on 3 May 2019, showcasing newest developments in cryo EM hardware, software and…